 <h1>Yervoy Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ipilimumab</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ipilimumab. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Yervoy.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ipilimumab: intravenous solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, ipilimumab (the active ingredient contained in Yervoy) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking ipilimumab:</p><p>
<i>More common</i>
</p><ul>
<li>Bloody, black, or tarry stools</li>
<li>diarrhea</li>
<li>fever</li>
<li>heartburn</li>
<li>indigestion</li>
<li>itching, skin rash</li>
<li>nausea</li>
<li>severe stomach pain, cramping, or burning</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>vomiting of material that looks like coffee grounds, severe and continuing</li>
<li>watery or bloody diarrhea</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blistering, crusting, irritation, itching, or reddening of the skin</li>
<li>bloody or cloudy urine</li>
<li>blurred vision or other changes in vision</li>
<li>burning, dry, or itching eyes</li>
<li>burning, tingling, numbness or pain in the hands, arms, feet, or legs</li>
<li>chest pain</li>
<li>chills</li>
<li>clay-colored stools</li>
<li>cough</li>
<li>cracked, dry, or scaly skin</li>
<li>dark urine</li>
<li>darkening of the skin</li>
<li>decreased appetite</li>
<li>decreased frequency or amount of urine</li>
<li>difficulty with breathing, chewing, swallowing, or talking</li>
<li>dizziness</li>
<li>double vision</li>
<li>drooping eyelids</li>
<li>drowsiness</li>
<li>eye discharge or excessive tearing</li>
<li>eye pain or sensitivity to light</li>
<li>fainting</li>
<li>headache, possibly severe</li>
<li>hives or welts</li>
<li>loss of appetite</li>
<li>mental depression</li>
<li>muscle weakness</li>
<li>pain, itching, burning, swelling, bleeding, or a lump under the skin where the needle was placed</li>
<li>painful or difficult urination</li>
<li>redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>sensation of pins and needles</li>
<li>severe tiredness</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stabbing pain</li>
<li>stomach tenderness</li>
<li>swelling of the face, feet, or lower legs</li>
<li>swollen glands</li>
<li>unusual bleeding or bruising</li>
<li>unusual weight gain</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Anxiety</li>
<li>bloating</li>
<li>blue or pale skin</li>
<li>chest pain, possibly moving to the left arm, neck, or shoulder</li>
<li>confusion</li>
<li>constipation</li>
<li>difficulty with moving</li>
<li>fast heartbeat</li>
<li>general feeling of discomfort or illness</li>
<li>increased thirst</li>
<li>lower back or side pain</li>
<li>muscle pain or stiffness</li>
<li>muscle weakness</li>
<li>pain or burning in the throat</li>
<li>pain, swelling, or redness in the joints</li>
<li>pains in the stomach or side, possibly radiating to the back</li>
<li>skin irritation or rash, including rash that looks like psoriasis</li>
<li>sores, welts, or blisters on the skin</li>
<li>stiff neck or back</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Back, leg, or stomach pains</li>
<li>bleeding gums</li>
<li>general body swelling</li>
<li>inability to move the arms and legs</li>
<li>nosebleeds</li>
<li>throbbing pain</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of ipilimumab may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Headache</li>
<li>trouble sleeping</li>
<li>weight loss</li>
</ul><p>
<!-- end intravenous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ipilimumab: intravenous solution</i></p><h3>General</h3><p>The most common side effects were diarrhea, rash, pruritus, fatigue, nausea, vomiting, decreased appetite, abdominal pain, and colitis.<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Sepsis, oral candidiasis, cellulitis, contrast media allergy, seasonal allergy</p>
<p><b>Uncommon</b> (0.1% to 1%): Septic shock, cytokine release syndrome, positive antinuclear antibody</p>
<p><b>Rare</b> (less than 0.1%): Sarcoidosis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Infectious hepatitis, increased blood bilirubin, increased alanine aminotransferase, increased aspartate aminotransferase, abnormal hepatic function, hepatic failure, hepatomegaly, jaundice</p>
<p><b>Uncommon</b> (0.1% to 1%): Autoimmune hepatitis, increased gamma-glutamyltransferase<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, flushing, hypertension, hematoma, venous thrombosis, hemorrhage, lymphedema, hot flush</p>
<p><b>Uncommon</b> (0.1% to 1%): Orthostatic hypotension, pericardial effusion</p>
<p><b>Rare</b> (less than 0.1%): Myocarditis, cardiomyopathy, angiopathy, peripheral ischemia, vasculitis, temporal arteritis, Raynaud's phenomenon<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Pruritus (up to 33%), rash (up to 30%)</p>
<p><b>Common</b> (1% to 10%): Erythema, vitiligo, alopecia, dry skin, night sweats, dermatitis, urticaria, eczema, skin hypopigmentation, contusion, excoriation</p>
<p><b>Uncommon</b> (0.1% to 1%): Toxic epidermal necrolysis, leukocytoclastic vasculitis, skin exfoliation, erythema multiforme, psoriasis, palmar-plantar erythrodysesthesia syndrome, erythema nodosum, hair color changes<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Decreased blood corticotrophin, hypopituitarism (including hypophysitis), hypothyroidism, adrenal insufficiency, hyperthyroidism</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased blood thyroid stimulating hormone, decreased blood cortisol, decreased blood testosterone, hypogonadism, thyroiditis, hypoparathyroidism, decreased blood thyroid stimulating hormone, decreased blood gonadotrophin, decreased thyroxin, abnormal blood prolactin, hypocalcemia</p>
<p><b>Rare</b> (less than 0.1%): Secondary adrenocortical insufficiency, hyperpituitarism, autoimmune thyroiditis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 38%), vomiting (up to 24%), abdominal pain (up to 23%), nausea</p>
<p><b>Common</b> (1% to 10%): Colitis, gastrointestinal hemorrhage, constipation, gastroesophageal reflux disease, stomatitis, dysphagia, retching, gastroenteritis, increased lipase, large intestine perforation, proctitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased blood amylase, gastrointestinal perforation, large intestinal ulcer, esophagitis, ileus, diverticulitis, gastric ulcer, enterocolitis, pancreatitis, peritonitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Lymphadenopathy, eosinophilia, neutropenia, thrombocytopenia, anemia, lymphopenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Hemolytic anemia, leucopenia, lymphocytosis</p>
<p><b>Rare</b> (less than 0.1%): Polycythemia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Lethargy, tremor, brain edema, cranial neuropathy, peripheral sensory neuropathy, aphasia, dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Guillain-Barr√© syndrome, meningitis (aseptic), syncope, ataxia, tremor, myoclonus, dysarthria, myasthenia gravis-like syndrome</p>
<p><b>Rare</b> (less than 0.1%): Meninginism, autoimmune central neuropathy (encephalitis), neurosensory hypoacusis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision, conjunctivitis, uveitis, eye pain, dry eye</p>
<p><b>Uncommon</b> (0.1% to 1%): Vitreous hemorrhage, iritis, reduced visual acuity, foreign body sensation in eyes, blepharitis, paresthesia, hypoesthesia</p>
<p><b>Rare</b> (less than 0.1%): Episcleritis, scleritis, eye edema, ocular myositis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (up to 42%), pyrexia (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Chest pain, chills, asthenia, edema, pain, influenza-like illness</p>
<p><b>Uncommon</b> (0.1% to 1%): Multi-organ failure, infusion related reaction, systemic inflammatory response syndrome, mucosal inflammation<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Renal failure, hematuria, increased blood creatinine</p>
<p><b>Uncommon</b> (0.1% to 1%): Glomerulonephritis, renal tubular acidosis, urinary tract infection</p>
<p><b>Rare</b> (less than 0.1%): Immune-mediated nephritis, proteinuria, renal dysfunction<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (up to 17%)</p>
<p><b>Common</b> (1% to 10%): Upper respiratory tract infection, lower respiratory tract infection, oropharyngeal pain, wheezing, nasal disorder, sinus, congestion, dyspnea</p>
<p><b>Uncommon</b> (0.1% to 1%): Respiratory failure, acute respiratory distress syndrome, lung infiltration, pulmonary edema, pneumonitis, allergic rhinitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Amenorrhea<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity</p>
<p><b>Very rare</b> (less than 0.01%): Anaphylactic reaction<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reaction (up to 50%)</p>
<p><b>Common</b> (1% to 10%): Vaccination site reaction<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (up to 27%)</p>
<p><b>Common</b> (1% to 10%): Hypokalemia, hypoglycemia, hypoalbuminemia, hyponatremia, decreased weight, dehydration, type 1 diabetes mellitus</p>
<p><b>Uncommon</b> (0.1% to 1%): Alkalosis, hypophosphatemia, tumor lysis syndrome</p>
<p><b>Rare</b> (less than 0.1%): Tumor lysis syndrome<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia, muscle spasms</p>
<p><b>Uncommon</b> (0.1% to 1%): Arthralgia, musculoskeletal pain, arthritis</p>
<p><b>Rare</b> (less than 0.1%): Polymyalgia rheumatica, myositis, polymyositis<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Tumor pain, cancer pain</p>
<p><b>Frequency not reported</b>: Paraneoplastic syndrome<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Depression, anxiety, decreased libido, confusional state</p>
<p><b>Uncommon</b> (0.1% to 1%): Mental status changes<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Yervoy (ipilimumab)." Bristol-Myers Squibb, Princeton, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Yervoy (ipilimumab)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: anti-CTLA-4 monoclonal antibodies</li>
<li>FDA Alerts (1)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Yervoy &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Melanoma, Metastatic</li>
<li>Colorectal Cancer</li>
<li>Malignant Pleural Mesothelioma</li>
<li>Melanoma</li>
<li>Renal Cell Carcinoma</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ipilimumab: intravenous solution</i></p><h3>General</h3><p>The most common side effects were diarrhea, rash, pruritus, fatigue, nausea, vomiting, decreased appetite, abdominal pain, and colitis.<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Sepsis, oral candidiasis, cellulitis, contrast media allergy, seasonal allergy</p><p><b>Uncommon</b> (0.1% to 1%): Septic shock, cytokine release syndrome, positive antinuclear antibody</p><p><b>Rare</b> (less than 0.1%): Sarcoidosis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Infectious hepatitis, increased blood bilirubin, increased alanine aminotransferase, increased aspartate aminotransferase, abnormal hepatic function, hepatic failure, hepatomegaly, jaundice</p><p><b>Uncommon</b> (0.1% to 1%): Autoimmune hepatitis, increased gamma-glutamyltransferase<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, flushing, hypertension, hematoma, venous thrombosis, hemorrhage, lymphedema, hot flush</p><p><b>Uncommon</b> (0.1% to 1%): Orthostatic hypotension, pericardial effusion</p><p><b>Rare</b> (less than 0.1%): Myocarditis, cardiomyopathy, angiopathy, peripheral ischemia, vasculitis, temporal arteritis, Raynaud's phenomenon<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Pruritus (up to 33%), rash (up to 30%)</p><p><b>Common</b> (1% to 10%): Erythema, vitiligo, alopecia, dry skin, night sweats, dermatitis, urticaria, eczema, skin hypopigmentation, contusion, excoriation</p><p><b>Uncommon</b> (0.1% to 1%): Toxic epidermal necrolysis, leukocytoclastic vasculitis, skin exfoliation, erythema multiforme, psoriasis, palmar-plantar erythrodysesthesia syndrome, erythema nodosum, hair color changes<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Decreased blood corticotrophin, hypopituitarism (including hypophysitis), hypothyroidism, adrenal insufficiency, hyperthyroidism</p><p><b>Uncommon</b> (0.1% to 1%): Increased blood thyroid stimulating hormone, decreased blood cortisol, decreased blood testosterone, hypogonadism, thyroiditis, hypoparathyroidism, decreased blood thyroid stimulating hormone, decreased blood gonadotrophin, decreased thyroxin, abnormal blood prolactin, hypocalcemia</p><p><b>Rare</b> (less than 0.1%): Secondary adrenocortical insufficiency, hyperpituitarism, autoimmune thyroiditis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 38%), vomiting (up to 24%), abdominal pain (up to 23%), nausea</p><p><b>Common</b> (1% to 10%): Colitis, gastrointestinal hemorrhage, constipation, gastroesophageal reflux disease, stomatitis, dysphagia, retching, gastroenteritis, increased lipase, large intestine perforation, proctitis</p><p><b>Uncommon</b> (0.1% to 1%): Increased blood amylase, gastrointestinal perforation, large intestinal ulcer, esophagitis, ileus, diverticulitis, gastric ulcer, enterocolitis, pancreatitis, peritonitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Lymphadenopathy, eosinophilia, neutropenia, thrombocytopenia, anemia, lymphopenia</p><p><b>Uncommon</b> (0.1% to 1%): Hemolytic anemia, leucopenia, lymphocytosis</p><p><b>Rare</b> (less than 0.1%): Polycythemia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 15%)</p><p><b>Common</b> (1% to 10%): Lethargy, tremor, brain edema, cranial neuropathy, peripheral sensory neuropathy, aphasia, dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Guillain-Barr√© syndrome, meningitis (aseptic), syncope, ataxia, tremor, myoclonus, dysarthria, myasthenia gravis-like syndrome</p><p><b>Rare</b> (less than 0.1%): Meninginism, autoimmune central neuropathy (encephalitis), neurosensory hypoacusis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision, conjunctivitis, uveitis, eye pain, dry eye</p><p><b>Uncommon</b> (0.1% to 1%): Vitreous hemorrhage, iritis, reduced visual acuity, foreign body sensation in eyes, blepharitis, paresthesia, hypoesthesia</p><p><b>Rare</b> (less than 0.1%): Episcleritis, scleritis, eye edema, ocular myositis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (up to 42%), pyrexia (up to 13%)</p><p><b>Common</b> (1% to 10%): Chest pain, chills, asthenia, edema, pain, influenza-like illness</p><p><b>Uncommon</b> (0.1% to 1%): Multi-organ failure, infusion related reaction, systemic inflammatory response syndrome, mucosal inflammation<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Renal failure, hematuria, increased blood creatinine</p><p><b>Uncommon</b> (0.1% to 1%): Glomerulonephritis, renal tubular acidosis, urinary tract infection</p><p><b>Rare</b> (less than 0.1%): Immune-mediated nephritis, proteinuria, renal dysfunction<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (up to 17%)</p><p><b>Common</b> (1% to 10%): Upper respiratory tract infection, lower respiratory tract infection, oropharyngeal pain, wheezing, nasal disorder, sinus, congestion, dyspnea</p><p><b>Uncommon</b> (0.1% to 1%): Respiratory failure, acute respiratory distress syndrome, lung infiltration, pulmonary edema, pneumonitis, allergic rhinitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Amenorrhea<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity</p><p><b>Very rare</b> (less than 0.01%): Anaphylactic reaction<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reaction (up to 50%)</p><p><b>Common</b> (1% to 10%): Vaccination site reaction<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (up to 27%)</p><p><b>Common</b> (1% to 10%): Hypokalemia, hypoglycemia, hypoalbuminemia, hyponatremia, decreased weight, dehydration, type 1 diabetes mellitus</p><p><b>Uncommon</b> (0.1% to 1%): Alkalosis, hypophosphatemia, tumor lysis syndrome</p><p><b>Rare</b> (less than 0.1%): Tumor lysis syndrome<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia, muscle spasms</p><p><b>Uncommon</b> (0.1% to 1%): Arthralgia, musculoskeletal pain, arthritis</p><p><b>Rare</b> (less than 0.1%): Polymyalgia rheumatica, myositis, polymyositis<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Tumor pain, cancer pain</p><p><b>Frequency not reported</b>: Paraneoplastic syndrome<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 12%)</p><p><b>Common</b> (1% to 10%): Depression, anxiety, decreased libido, confusional state</p><p><b>Uncommon</b> (0.1% to 1%): Mental status changes<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Yervoy (ipilimumab)." Bristol-Myers Squibb, Princeton, NJ. </p><h2>More about Yervoy (ipilimumab)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: anti-CTLA-4 monoclonal antibodies</li>
<li>FDA Alerts (1)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Yervoy &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Melanoma, Metastatic</li>
<li>Colorectal Cancer</li>
<li>Malignant Pleural Mesothelioma</li>
<li>Melanoma</li>
<li>Renal Cell Carcinoma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>